Ursprung des Netzwerks ersten Grades von Benjamin Charles
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
DiogenX SAS
DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benjamin Charles
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
HAVAS | Advertising/Marketing Services | Director/Board Member | |
THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Operating Officer | |
VIVENDI SE | Media Conglomerates | Corporate Officer/Principal | |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Capillary Biomedical LLC
Capillary Biomedical LLC Medical SpecialtiesHealth Technology Capillary Biomedical, Inc. develops medical devices for diabetes management. The company was founded by Jeffrey Joseph and Paul Strasma and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member | |
ASSYSTEM | Engineering & Construction | Director/Board Member | |
CS GROUP | Data Processing Services | Director/Board Member | |
UGC SA
UGC SA Movies/EntertainmentConsumer Services UGC SA operates movie theaters and provides motion picture and tape distribution services. The firm also broadcasts films. The company has operations in Belgium, Spain, British Isles and the US. The company was founded in 1971 and is headquartered in Neuilly-sur-Seine, France. | Movies/Entertainment | Director/Board Member | |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
STUDIO BABELSBERG AG | Movies/Entertainment | Director/Board Member | |
Yale University | College/University | Undergraduate Degree | |
NEOVACS | Pharmaceuticals: Major | President | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
University of Hohenheim | College/University | Undergraduate Degree | |
Ecole Nationale d'Administration | College/University | Undergraduate Degree | |
Aloe Private Equity (UK) Ltd.
Aloe Private Equity (UK) Ltd. Investment ManagersFinance Aloe Private Equity (UK) Ltd. operates as a private equity firm with interests in waste management and metallurgy industries. The firm serves for different industry sectors including the environment, energy, software, information technology, retail and media. The company was founded by Vivek Tandon and Jean-Pascal Tranié in 2003 and is headquartered in Twyford, the United Kingdom. | Investment Managers | Founder | |
Aloe Private Equity SAS
Aloe Private Equity SAS Investment ManagersFinance Aloe Private Equity SAS is an Independent Private Equity firm founded in 2003 by Vivek Tandon and Jean-Pascal Tranié. Aloe Private Equity SAS is headquartered in Paris with additional offices in Twyford, Beijing and Mumbai. | Investment Managers | Founder | |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Investment Managers | Private Equity Investor | |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Founder | |
AGROGENERATION | Agricultural Commodities/Milling | Director/Board Member | |
Activision Entertainment Holdings, Inc.
Activision Entertainment Holdings, Inc. Media ConglomeratesConsumer Services Part of Vivendi SE, Activision Entertainment Holdings, Inc. provides entertainment services. The company is based in Santa Monica, CA. | Media Conglomerates | Corporate Officer/Principal | |
Boehringer Ingelheim (Venture Capital)
Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Eurl Edenworld | Corporate Officer/Principal | ||
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Luxfold S.A.
Luxfold S.A. BiotechnologyHealth Technology Luxfold S.A. designs and engineers protein structures. It offers protein three-dimensional structure. The company is headquartered in Luxembourg. | Biotechnology | Founder | |
Longmen Group Ltd.
Longmen Group Ltd. Contract DrillingIndustrial Services Longmen Group Ltd. develops and produces coal bed methane gas. It also involves in the exploration and development of natural gas. The company was founded in 2005 and is headquartered in Cybercity Ebene, Mauritius. . | Contract Drilling | Director/Board Member | |
Aloe Energy SASU
Aloe Energy SASU Electric UtilitiesUtilities Aloe Energy SASU owns and operates photovoltaic energy production project sites. The company was founded in 2014 and is headquartered in La Ciotat cedex, France. | Electric Utilities | Chairman | |
Centauri Therapeutics Ltd.
Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
AdBio Partners SAS
AdBio Partners SAS Investment ManagersFinance AdBio Partners SAS (AdBio Partners) is a venture capital firm founded in 2015. The firm is headquartered in Paris, France. | Investment Managers | Founder | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Assystem Brime SA | Director/Board Member | ||
Compagnie Générale De Vidéocommunication | Chief Executive Officer | ||
Aol France SNC
Aol France SNC Specialty TelecommunicationsCommunications Aol France SNC provides telecommunication activities. The private company is based in Paris, France. | Specialty Telecommunications | Corporate Officer/Principal | |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Director/Board Member | |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
I2o Therapeutics, Inc.
I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Urania Therapeutics SAS
Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Chairman | |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Augustine Therapeutics NV
Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Tech Health Experts
Tech Health Experts Information Technology ServicesTechnology Services Tech Health Experts provides technical support services. | Information Technology Services | Consultant / Advisor | |
SAB BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
Frankreich | 26 |
Vereinigte Staaten | 12 |
Vereinigtes Königreich | 5 |
Deutschland | 4 |
Belgien | 3 |
Sektoral
Health Technology | 13 |
Consumer Services | 11 |
Finance | 11 |
Commercial Services | 7 |
Industrial Services | 3 |
Operativ
Director/Board Member | 26 |
Founder | 7 |
Private Equity Investor | 7 |
Corporate Officer/Principal | 7 |
Chairman | 6 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jean-Pascal Tranié | 22 |
Alain Huriez | 12 |
Katie Ellias | 11 |
Johannes Zanzinger | 8 |
Glyn Parkin | 2 |
Patrick Collombat | 1 |
David Evans | 1 |
- Börse
- Insiders
- Benjamin Charles
- Unternehmensverbindungen